Acquisition - Additional Information (Detail) - USD ($) |
Jun. 11, 2018 |
Aug. 31, 2020 |
Nov. 30, 2019 |
|---|---|---|---|
| Business Acquisition [Line Items] | |||
| Common stock par value | $ 0.01 | $ 0.01 | |
| Goodwill | $ 1,941,411 | $ 1,941,411 | |
| Blood Bank Inc and Tianhe Stem Cell Biotechnologies Inc [Member] | |||
| Business Acquisition [Line Items] | |||
| Aggregate consideration payable at closing under the Purchase Agreement | $ 14,000,000 | ||
| Payment under asset purchase agreement | $ 10,500,000 | ||
| Shares issued under asset purchase agreement | 465,426 | ||
| Common stock par value | $ 0.01 | ||
| Sale of stock price per share | $ 7.52 | ||
| Percentage of earn out to be paid from gross revenues | 75.00% | ||
| Common stock deliver | $ 200,000 | ||
| Common stock value | 5,000,000 | ||
| Amount of earn out to be paid from sale of public cord blood inventory | $ 500,000 |
| X | ||||||||||
- Definition Business Acquisition amount of Earn Out to Be Paid from Sale of Public Cord Blood Inventory No definition available.
|
| X | ||||||||||
- Definition Business acquisition common shares value. No definition available.
|
| X | ||||||||||
- Definition Business combination consideration shares transferred. No definition available.
|
| X | ||||||||||
- Definition Business Combination Consideration Transferred At Closing No definition available.
|
| X | ||||||||||
- Definition Common stock transferred for cash value. No definition available.
|
| X | ||||||||||
- Definition Percentage of Earn Out to Be Paid from Gross Revenues No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|